Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.
Oliva A, Liguori L, Covino S, Petrucci F, Cogliati-Dezza F, Curtolo A, Savelloni G, Comi M, Sacco F, Ceccarelli G, Viscido A, Alessandri F, Raponi G, Pugliese F, Mastroianni CM, Venditti M. Oliva A, et al. Among authors: cogliati dezza f. Eur J Clin Microbiol Infect Dis. 2024 Apr 18. doi: 10.1007/s10096-024-04833-8. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38634975
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients.
Zingaropoli MA, Guardiani M, Dominelli F, Tortellini E, Garofalo M, Cogliati Dezza F, Centofanti A, Carillo C, Napoli A, Venuta F, Mastroianni CM, Pretagostini R, Lichtner M, Ciardi MR, Russo G. Zingaropoli MA, et al. Among authors: cogliati dezza f. Vaccines (Basel). 2024 Feb 22;12(3):224. doi: 10.3390/vaccines12030224. Vaccines (Basel). 2024. PMID: 38543858 Free PMC article.
Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization.
Cogliati Dezza F, Covino S, Petrucci F, Sacco F, Viscido A, Gavaruzzi F, Ceccarelli G, Raponi G, Borrazzo C, Alessandri F, Mastroianni CM, Venditti M, Oliva A. Cogliati Dezza F, et al. JAC Antimicrob Resist. 2023 Aug 10;5(4):dlad096. doi: 10.1093/jacamr/dlad096. eCollection 2023 Aug. JAC Antimicrob Resist. 2023. PMID: 37577156 Free PMC article.
Gli invisibili in periferia.
Carrozzini A, Gatti C, De Michele F, Sallustio A, Cogliati Dezza F, Brogi T, Villa A, D'Innocenzo L, Carpino M, Ariani L, Marini M, Pontoriero A. Carrozzini A, et al. Among authors: cogliati dezza f. Recenti Prog Med. 2023 Sep;114(9):538. doi: 10.1701/4088.40803. Recenti Prog Med. 2023. PMID: 37530010 Italian. No abstract available.
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.
Oliva A, Cogliati Dezza F, Petrucci F, Romani FE, Morviducci M, Mirabelli FM, Cancelli F, Valeriani E, Marcelli G, Pugliese F, Turriziani O, Ricci P, Venditti M, Palange P, Mastroianni CM. Oliva A, et al. Among authors: cogliati dezza f. Clin Exp Med. 2023 Oct;23(6):2275-2285. doi: 10.1007/s10238-023-01027-y. Epub 2023 Mar 3. Clin Exp Med. 2023. PMID: 36867292 Free PMC article.
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study.
Oliva A, Volpicelli L, Di Bari S, Curtolo A, Borrazzo C, Cogliati Dezza F, Cona A, Agrenzano S, Mularoni A, Trancassini M, Mengoni F, Stefani S, Raponi G, Venditti M. Oliva A, et al. Among authors: cogliati dezza f. JAC Antimicrob Resist. 2022 Dec 7;4(6):dlac121. doi: 10.1093/jacamr/dlac121. eCollection 2022 Dec. JAC Antimicrob Resist. 2022. PMID: 36506890 Free PMC article.
Evaluation of Immunogenicity to Three Doses of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Lung Transplant Patients.
Guardiani M, Zingaropoli MA, Cogliati Dezza F, Centofanti A, Carillo C, Tortellini E, Dominelli F, Napoli A, Del Borgo C, Gaeta A, Venuta F, Vullo V, Lichtner M, Ciardi MR, Mastroianni CM, Russo G. Guardiani M, et al. Among authors: cogliati dezza f. Vaccines (Basel). 2022 Sep 30;10(10):1642. doi: 10.3390/vaccines10101642. Vaccines (Basel). 2022. PMID: 36298507 Free PMC article.
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
Oliva A, Curtolo A, Volpicelli L, Cancelli F, Borrazzo C, Cogliati Dezza F, Marcelli G, Gavaruzzi F, Di Bari S, Ricci P, Turriziani O, Mastroianni CM, Venditti M. Oliva A, et al. Among authors: cogliati dezza f. Infection. 2022 Oct;50(5):1383. doi: 10.1007/s15010-022-01892-x. Infection. 2022. PMID: 35900672 Free PMC article. No abstract available.
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared.
Cogliati Dezza F, Arcari G, Alessi F, Valeri S, Curtolo A, Sacco F, Ceccarelli G, Raponi G, Alessandri F, Mastroianni CM, Venditti M, Oliva A. Cogliati Dezza F, et al. Antibiotics (Basel). 2022 Jul 9;11(7):926. doi: 10.3390/antibiotics11070926. Antibiotics (Basel). 2022. PMID: 35884179 Free PMC article.
19 results